Showing results (441-450 of 526) with videos related to
Sort By:
Pageof 53
Advances in Radiation Oncology|April 11, 2025
Cell-Free Circulating Tumor DNA for NonInvasive Molecular Profiling Among Patients Undergoing Definitive Chemoradiation for Locally Advanced Lung CancerEmily S Lebow, Jordan Eichholz, Lillian Boe, et al.International Journal of Radiation Oncology, Biology, Physics|September 27, 2021
American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung CancerArya Amini, Vivek Verma, Charles B Simone, et al.International Journal of Radiation Oncology, Biology, Physics|November 24, 2023
Predicting the Effect of Proton Beam Therapy Technology on Pulmonary Toxicities for Patients With Locally Advanced Lung Cancer Enrolled in the Proton Collaborative Group Prospective Clinical TrialGilmer Valdes, Jessica Scholey, Tomi F Nano, et al.International Journal of Radiation Oncology, Biology, Physics|April 4, 2022
Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 StudyLei He, Yaxuan Pi, Yi Li, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registryArpit M Chhabra, Stephanie R Rice, Adam Holtzman, et al.Radiation Oncology (London, England)|April 2, 2025
Gantry-based pencil beam scanning proton therapy for uveal melanoma: IMPT versus proton arc therapyHang Qi, Lei Hu, Sheng Huang, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2026
Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical TrialsXiaoying Liang, Paige A Taylor, Heng Li, et al.Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
Clinical outcomes of black vs. non-black patients with locally advanced non-small cell lung cancerMelissa A L Vyfhuis, Neha Bhooshan, Jason Molitoris, et al.JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2021
Management of Stage III Non-Small-Cell Lung Cancer: ASCO GuidelineMegan E Daly, Navneet Singh, Nofisat Ismaila, et al.Pageof 53